Bg pattern

MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Montelukast Viatris 10 mg Film-Coated Tablets EFG

Read the package leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this package leaflet, you may need to read it again. If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Montelukast Viatris and what is it used for
  2. What you need to know before you take Montelukast Viatris
  3. How to take Montelukast Viatris
  4. Possible side effects
  5. Storage of Montelukast Viatris
  6. Contents of the pack and further information

1. What is Montelukast Viatris and what is it used for

Montelukast Viatris contains montelukast, which is a leukotriene receptor antagonist that blocks substances called leukotrienes. Leukotrienes cause the airways to narrow and swell, and can also cause allergy symptoms. By blocking the leukotrienes, Montelukast Viatris improves asthma symptoms, helps control asthma, and improves symptoms of seasonal allergies (also known as hay fever or allergic rhinitis).

Your doctor has prescribed Montelukast Viatris to treat asthma and prevent asthma symptoms during the day and night.

  • Montelukast Viatris is used for the treatment of adults and adolescents 15 years of age and older who are not adequately controlled with their medication and need additional treatment.
  • Montelukast Viatris also helps prevent narrowing of the airways caused by exercise.
  • In patients with asthma who are indicated for Montelukast Viatris for asthma, it may also provide symptomatic relief of seasonal allergic rhinitis.

Depending on your symptoms and the severity of your asthma, your doctor will determine how you should use Montelukast Viatris.

Montelukast Viatris 10 mg film-coated tablets are used in adults and adolescents 15 years of age and older.

What is Asthma?

Asthma is a chronic disease.

Asthma includes:

  • Difficulty breathing due to narrowing of the airways. This narrowing of the airways gets worse and better in response to various diseases.
  • Airways that are sensitive and react to many things, such as cigarette smoke, pollen, cold air, or exercise.
  • Swelling (inflammation) of the inner layer of the airways.

The symptoms of asthma include: coughing, wheezing, and chest congestion.

What are Seasonal Allergies?

Seasonal allergies (also known as hay fever or allergic rhinitis) are an allergic reaction often caused by airborne pollen from trees, grass, and weeds. Symptoms of seasonal allergies typically include: stuffy nose, runny nose; sneezing; itchy, watery, red, and swollen eyes.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Montelukast Viatris

Tell your doctor about any allergy or medical problem you have now or have had.

Do not take Montelukast Viatris:

  • If you are allergic to montelukast or any of the other ingredients of this medicine (listed in section 6).

Warnings and Precautions

Consult your doctor or pharmacist before starting Montelukast Viatris.

  • If your asthma or breathing gets worse, tell your doctor immediately.
  • Montelukast Viatris is not indicated for the treatment of acute asthma attacks. If an attack occurs, follow the instructions given by your doctor. Always have your rescue inhaler medication for asthma attacks.

Consult your doctor if you need more inhaler medication than usual for severe asthma attacks.

  • It is important that you take all asthma medications prescribed by your doctor. Montelukast Viatris should not replace other asthma medications prescribed by your doctor.
  • Any patient being treated with asthma medications should be aware that if they develop a combination of symptoms such as flu-like illness, tingling or numbness of arms or legs, worsening lung symptoms (pulmonary symptoms), and/or skin rash, they should consult their doctor.
  • Do not take aspirin or non-steroidal anti-inflammatory drugs (also known as non-steroidal anti-inflammatory medications or NSAIDs) if they make your asthma worse.

Neuropsychiatric events (such as changes related to behavior and mood, depression, suicide) have been reported in patients of all ages treated with montelukast (see section 4). If you develop such symptoms while taking montelukast, you should consult your doctor.

Children and Adolescents

Do not give this medicine to children under 15 years of age.

For pediatric patients under 18 years of age, other formulations of this medicine are available based on the age range.

Other Medicines and Montelukast Viatris

Some medicines may affect the way Montelukast Viatris works, or Montelukast Viatris may affect the way other medicines work.

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.

Before taking Montelukast Viatris, tell your doctor if you are taking the following medicines:

  • Phenobarbital (used to treat epilepsy).
  • Phenytoin (used to treat epilepsy).
  • Rifampicin (used to treat tuberculosis and some other infections).
  • Gemfibrozil (used to treat high lipid levels in plasma).

Pregnancy, Breastfeeding, and Fertility

Pregnancy

If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine. Your doctor will assess whether you can take Montelukast Viatris during this period.

Breastfeeding

It is not known whether Montelukast Viatris appears in breast milk. If you are breastfeeding or plan to breastfeed, you should inform your doctor before taking Montelukast Viatris.

Driving and Using Machines

Montelukast Viatris is not expected to affect your ability to drive a car or operate machinery. However, individual responses to the medication may vary. Some side effects (such as drowsiness or dizziness) reported with Montelukast Viatris may affect the patient's ability to drive or operate machinery.

Montelukast Viatris contains Orange Yellow S and Sodium

Orange Yellow S (E-110) may cause allergic reactions.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".

.

3. How to take Montelukast Viatris

Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

  • You should take only one Montelukast Viatris tablet once a day, as prescribed by your doctor.
  • You should take it even when you do not have symptoms or when you have an acute asthma attack.

For Adults (including elderly patients) and Adolescents 15 years of age and older:

The recommended dose is:

  • One 10 mg tablet, once daily, in the evening.

Use in Children and Adolescents

Montelukast Viatris is not suitable for children and adolescents under 15 years of age.

If you are taking Montelukast Viatris, make sure you do not take any other product that contains the same active ingredient, montelukast.

This medicine is taken orally.

You can take Montelukast Viatris with or without food.

If you take more Montelukast Viatris than you should

Seek help from your doctor immediately.

In most cases of overdose, no adverse effects were reported. The symptoms that occurred most frequently, reported in overdose, were abdominal pain, drowsiness, thirst, headache, vomiting, and hyperactivity.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Montelukast Viatris

Try to take Montelukast Viatris as prescribed. However, if you miss a dose, just resume your regular schedule of one tablet once a day.

Do not take a double dose to make up for missed doses.

If you stop taking Montelukast Viatris

Montelukast Viatris may only treat your asthma if you continue to take it. It is important that you continue to take Montelukast Viatris for the time your doctor prescribes. It will help control your asthma.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

In clinical trials conducted with montelukast, the side effects related to the administration of montelukast and reported most frequently (occurring in up to 1 in 10 people) were:

  • Abdominal pain.
  • Headache.

These side effects were generally mild and occurred more frequently in patients treated with montelukast than with placebo (a pill that does not contain medicine).

Serious side effects

Contact a doctor immediatelyif you notice any of the following side effects, which may be serious and require urgent medical treatment.

Uncommon(may affect up to 1 in 100 people)

  • Allergic reactions including swelling of the face, lips, tongue, or throat that may cause difficulty breathing or swallowing.
  • Changes related to behavior and mood: agitation including aggressive behavior and hostility, depression.
  • Seizures

Rare(may affect up to 1 in 1,000 people)

  • Increased risk of bleeding.
  • Tremor.
  • Palpitations.

Very rare(may affect up to 1 in 10,000 people)

  • A combination of symptoms such as flu-like illness, tingling or numbness of arms and legs, worsening lung symptoms (pulmonary symptoms), and/or skin rash (Churg-Strauss syndrome) (see section 2).
  • Low platelet count in blood.
  • Changes related to behavior and mood: hallucinations, disorientation, suicidal thoughts and actions.
  • Lung inflammation.
  • Severe skin reactions (erythema multiforme) that may appear without warning.
  • Liver inflammation (hepatitis).

Additionally, since the medicine has been marketed, the following side effects have been reported:

Very common(may affect more than 1 in 10 people)

  • Upper respiratory tract infections.

Common(may affect up to 1 in 10 people)

  • Diarrhea.
  • Nausea.
  • Vomiting.
  • Rash.
  • Fever.
  • Increased liver enzymes.

Uncommon(may affect up to 1 in 100 people)

  • Changes related to behavior and mood: sleep disturbances, including nightmares, sleepwalking, irritability, anxiety, restlessness, dizziness, drowsiness, tingling/numbness.
  • Nosebleeds.
  • Dry mouth, indigestion.
  • Bruising, itching, urticaria.
  • Joint or muscle pain, muscle cramps.
  • In the case of children, bedwetting.
  • Weakness/tiredness, malaise, swelling.

Rare(may affect up to 1 in 1,000 people)

  • Changes related to behavior and mood: attention disturbance, memory impairment, uncontrolled muscle movements.

Very rare(may affect up to 1 in 10,000 people)

  • Painful red lumps under the skin, most commonly on the shins (erythema nodosum).
  • Changes related to behavior and mood: obsessive-compulsive symptoms, stuttering.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible that they are not listed in this package leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Montelukast Viatris

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and further information

Composition of Montelukast Viatris

  • The active substance is montelukast.
  • Each tablet contains 10 mg of montelukast in the form of montelukast sodium.
  • The other ingredients are:

Core:microcrystalline cellulose, mannitol, sodium croscarmellose, magnesium stearate, sodium lauryl sulfate, anhydrous colloidal silica.

Coating:polydextrose, titanium dioxide (E-171), hypromellose, triacetin, carmine indigo (E-132), macrogol, orange yellow S (E-110) (see section 2 "Montelukast Viatris contains orange yellow S (E-110)")

Appearance of the product and pack contents

Film-coated tablets, blue, round, biconvex, with beveled edges, engraved with "MO" over "10" on one side and "M" on the other.

Available in blister packs of 10, 14, 20, 28, 30, 50, 56, 60, 84, 90, and 100 tablets, in unit-dose blister packs of 28x1 tablets or in bottles with silica gel desiccant containing 28, 30, 56, 60, 84, 90, 100, 112, 120, 180, and 500 tablets.

Not all pack sizes may be marketed.

Marketing Authorization Holder:

Viatris Limited

Damastown Industrial Park

Mulhuddart, Dublin 15

Dublin

Ireland

Manufacturer:

McDermott Laboratories Limited trading as Gerard Laboratories

35/36 Baldoyle Industrial Estate

Grange Road, Dublin 13

Ireland

or

Mylan Hungary Kft.

H-2900 Komárom,

Mylan utca.1

Hungary

or

Logiters, Logística Portugal, S.A.

Estrada dos Arneiros, 4

Azambuja, 2050-306

Portugal

or

Mylan B.V.

Krijgsman 20

1186DM Amstelveen

Netherlands

You can request more information about this medicine by contacting the local representative of the marketing authorization holder:

Viatris Pharmaceuticals, S.L.U.

C/ General Aranaz, 86

28027 - Madrid

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

Austria: Montelukast Arcana 10 mg Filmtabletten

Germany: Montelukast dura 10 mg filmtabletten

Cyprus: Montelukast Mylan επικαλυμμ?νο με λεπτ? υμ?νιο δισκ?ο 10 mg

Denmark: Montelukast Mylan

Slovakia: Montelukast Mylan 10 mg

Spain: Montelukast Viatris 10 mg film-coated tablets EFG

Finland: Montelukast Mylan

France: MONTELUKAST VIATRIS 10 mg, film-coated tablet

Greece: Montelukast Mylan επικαλυμμ?νο με λεπτ? υμ?νιο δισκ?ο 10 mg

Ireland: Montelukast Mylan 10 mg film-coated tablets

Italy: Montelukast Mylan Generics

Netherlands: Montelukast Mylan 10 mg, filmomhulde tabletten

Portugal: Montelucaste Mylan

United Kingdom (Northern Ireland): Montelukast 10 mg film-coated tablets

Czech Republic: Montelukast Mylan 10 mg, potahované tablety

Sweden: Montelukast Mylan

Date of last revision of this package leaflet:January 2025

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.gob.es/

Online doctors for MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS

Discuss questions about MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (760)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS?
MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS?
The active ingredient in MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS is montelukast. This information helps identify medicines with the same composition but different brand names.
How much does MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS is around 21.06 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS?
MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS is manufactured by Viatris Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MONTELUKAST VIATRIS 10 mg FILM-COATED TABLETS?
Other medicines with the same active substance (montelukast) include MONKASTA 10 mg FILM-COATED TABLETS, MONKASTA 4 mg CHEWABLE TABLETS, MONKASTA 5 mg CHEWABLE TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media